Encompass Health Corp Stock Price, News & Analysis

Encompass Health Corp. (NYSE: EHC) is exploring strategic alternatives for its home health and hospice business, considering options like an IPO, spin-off, merger, or sale. The company has experienced substantial growth since merging with Encompass Home Health and Hospice in 2015. As part of this review, the board is assessing potential corporate structures to enhance growth. There is no set timeline for the review’s completion, and the company will disclose updates only as directed by its Board. Citi and Wachtell, Lipton, Rosen, and Katz are advising on the process.

Encompass Health Corp. (NYSE: EHC) has opened the Encompass Health Rehabilitation Hospital of Toledo, Ohio, marking its fourth rehabilitation facility in the state. The hospital, located at 4647 Monroe Street, features 40 private patient rooms, advanced rehabilitation technology, and specialized care for patients recovering from severe illnesses and injuries such as strokes and spinal cord injuries. This facility aims to provide high-quality, integrated care to improve patient outcomes and restore independence.

Encompass Health Corp. (NYSE: EHC) has received a certificate of need from the Illinois Health Facilities Board to build a new 40-bed inpatient rehabilitation hospital in Shiloh, Illinois. This facility, set to be a joint venture with BJC HealthCare, will provide essential rehabilitation services, including physical, occupational, and speech therapies. The hospital will focus on patients recovering from severe conditions like strokes and brain injuries, featuring private rooms and advanced rehabilitation technologies. This expansion aims to meet the growing demand for quality care in the Metro East area.

Encompass Health Corp. (EHC) reported Q3 2020 results with net operating revenues of $1,173.9 million, up 1.1% from Q3 2019. Income per diluted share fell 20.4% to $0.78 due to increased depreciation, amortization, and interest expenses. Cash flows from operations rose 51.6%, reaching $173.4 million. Inpatient revenue grew by 3.8% but home health revenue declined 6.5%. The company anticipates Q4 revenues between $1,150 million and $1,220 million and adjusted earnings per share of $0.79 to $0.90.

Encompass Health Corp. (NYSE: EHC) has declared a quarterly cash dividend of $0.28 per share on its common stock. This dividend is set to be paid on January 15, 2021, to shareholders on record as of January 4, 2021. The company operates a comprehensive network of 136 inpatient rehabilitation hospitals, 245 home health locations, and 83 hospice locations across 39 states and Puerto Rico, focusing on high-quality, integrated healthcare services.

Encompass Health Corp. (NYSE: EHC) has been recognized for the ninth consecutive year in Modern Healthcare's Best Places to Work in Healthcare for 2020. The company's inpatient rehabilitation hospital segment ranked No. 42 and its home health and hospice segment No. 31 in the healthcare provider/insurer category. Encompass Health credits its dedicated employees for overcoming challenges during the COVID-19 pandemic, reinforcing its commitment to patient care and workplace culture.

Encompass Health Corporation (NYSE: EHC) announced the redemption of $700 million in 5.75% senior notes due 2024, set to settle on November 1, 2020, at par value. The redemption will be funded using proceeds from a recent $400 million public offering of senior unsecured notes due 2031 and available cash. This strategic move aims to optimize the company's capital structure and financial strategy amidst ongoing market challenges.

Encompass Health Corporation (NYSE: EHC) has priced a public offering of $400 million in 4.625% senior notes due 2031 at 100% of the principal amount. The offering is set to close on October 5, 2020, contingent on customary conditions. Proceeds will be used to redeem existing 5.75% Senior Notes due 2024. The notes will be guaranteed by current and future subsidiaries. Major underwriters include Truist Securities, Barclays, and others. This transaction follows an effective shelf registration statement with the SEC.

Encompass Health Corporation (NYSE: EHC) has announced a public offering of $400 million in senior notes maturing in 2031. The company plans to use the net proceeds, along with $300 million in cash, to fully redeem its 5.75% Senior Notes due in 2024 at par. The offering is led by a group of financial institutions including Truist Securities and Barclays, and is made under an effective registration statement filed with the SEC. Investors are encouraged to read the prospectus for detailed information.